| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1976.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Department of Pathobiology (E.B., C.-c.K., T.-M.L., L.A.C., F.B., B.C., M.E.R.) and the Interdisciplinary Graduate Program in Nutritional Sciences (F.B., M.E.R.), University of Washington, Seattle.
Correspondence to Michael Rosenfeld, PhD, Department of Pathobiology and Interdisciplinary Graduate Program in Nutritional Science, Box 353410, University of Washington, Seattle, WA 98195. E-mail ssmjm{at}u.washington.edu
Background It has not yet been determined whether lipid-loaded macrophages (foam cells), a major cellular component of atherosclerotic lesions, have the capacity to support growth of Chlamydia pneumoniae and be activated to secrete proinflammatory cytokines in response to C pneumoniae infection.
Methods and Results Lipid loading of RAW 264.7 cells and mouse peritoneal macrophages with either oxidized or acetylated LDL significantly inhibits the growth of C pneumoniae. Modified forms of LDL are not directly toxic to C pneumoniae and do not inhibit either the initial binding or internalization of C pneumoniae by macrophages. Lipid loading does not reduce infection of macrophages with Chlamydia trachomatis. Treatment of lipid-loaded macrophages with live, heat-killed, or UV-inactivated C pneumoniae stimulates secretion of cytokines. C pneumoniae also induces expression of the mRNA for tumor necrosis factor-
in foam cells despite inhibition of nuclear factor-
B binding to DNA by prior treatment with oxidized LDL.
Conclusions Foam cell formation is not conducive to growth of C pneumoniae but does not inhibit the C pneumoniaeinduced secretion of proinflammatory cytokines.
Key Words: atherosclerosis lipids leukocytes inflammation infection
This article has been cited by other articles:
![]() |
C. Grunfeld and K. R. Feingold HDL and innate immunity: a tale of two apolipoproteins J. Lipid Res., August 1, 2008; 49(8): 1605 - 1606. [Full Text] [PDF] |
||||
![]() |
F. N. Wuppermann, K. Molleken, M. Julien, C. A. Jantos, and J. H. Hegemann Chlamydia pneumoniae GroEL1 Protein Is Cell Surface Associated and Required for Infection of HEp-2 Cells J. Bacteriol., May 15, 2008; 190(10): 3757 - 3767. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yaraei, L. A. Campbell, X. Zhu, W. C. Liles, C.-c. Kuo, and M. E. Rosenfeld Chlamydia pneumoniae Augments the Oxidized Low-Density Lipoprotein-Induced Death of Mouse Macrophages by a Caspase-Independent Pathway Infect. Immun., July 1, 2005; 73(7): 4315 - 4322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Kazemi, C. M. McDonald, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1220 - 1224. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |